Skip to content
Home/Companies/Biotech/Biocrates
BI

Biocrates

Biotech·Austria·Exited 2025·Held 6yr

Biocrates is a biotech company, headquartered in Austria.

Entry
2019
Hold
6yr
Exit
2025
Est. EV
–

Who owns Biocrates?

Biocrates was owned by MIG Capital through MIG Fonds 16 (2019 vintage) from 2019 to 2025, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

MIG Capital
Investor
MIG Capital
MIG Fonds 16 · 2019 · Evergreen

Key facts

HQAustria
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025

More from MIG Fonds 16

Other portfolio companies in the same fund.

mbiomics
Active
BiotechGermany· 2023
Inbolt
Active
Deep TechFrance· 2022
iOmx Therapeutics
Active
BiotechGermany· 2021
Mimi Hearing Technologies
Active
IndustrialsGermany· 2021
Zadient Technologies
Active
Deep TechFrance· 2021
Innatera
Active
Deep TechNetherlands· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings